๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metabolism of selenium in humans

โœ Scribed by P.D. Whanger


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
159 KB
Volume
11
Category
Article
ISSN
0896-548X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Selenium (Se) metabolism in humans is discussed. More selenium as selenomethionine (Semet) is absorbed than when it is present as selenite (95-97% vs. 44-70%). The selenium content in blood is correlated with GPX activity in selenium-deficient Chinese and in New Zealanders, but it is not correlated in blood of subjects living in the states of Oregon or South Dakota in the United States. Selenium from Semet accumulates in blood at a faster rate than selenate, but there are no differences in the GPX activities. Similarly, no differences occurred in the accumulation of selenium in GPX when Semet was compared to selenate, but a difference was found in the accumulation of selenium in hemoglobin (erythrocytes) and albumin (plasma) in subjects taking these two forms of selenium. The majority of selenium in plasma is usually present in selenoprotein P, but with high intakes of Semet, the amount in albumin predominates. Stable isotopes were used to develop the concept of ''selenite exchangeable pool,'' which can be employed to assess the body burden of selenium in humans. The renal clearance of selenium is higher for Semet than selenate. Even though the maximum safe intake of selenium for humans was estimated to be 600 g per day, with use of a safety factor, 400 g was suggested as the maximum safe intake on a long-term basis. An intake of 40 g was suggested as the minimum amount required for humans, and intakes of less than 11 g will definitely put people at risk of deficiency. J.


๐Ÿ“œ SIMILAR VOLUMES


Metabolism of benoxinate in humans
โœ Fumiyo Kasuya; Kazuo Igarashi; Miyoshi Fukui ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 385 KB
Metabolism of phthalates in humans
โœ Hanne Frederiksen; Niels E. Skakkebaek; Anna-Maria Andersson ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 702 KB

## Abstract Phthalates are synthetic compounds widely used as plasticisers, solvents and additives in many consumer products. Several animal studies have shown that some phthalates possess endocrine disrupting effects. Some of the effects of phthalates seen in rats are due to testosterone lowering

Folate metabolism in humans
โœ Erbe, Richard W. ;Wang, Jin-Chen C. ;Opitz, John M. ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 621 KB
Pharmacokinetics and metabolism of codei
โœ Dr Tom B. Vree; Corrien P. W. G. M. Verwey-Van Wissen ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 716 KB

Codeine (30 mg phosphate) was metabolized by eight human volunteers to the following six metabolites: codeine-6-glucuronide 81 .O+ 9.3 per cent, norcodeine 2.16? 1.44 per cent, morphine 0-562 0-39 per cent, morphine-3-glucuronide 2-10? 1-24 per cent, morphine-6-glucuronide 0-80k 0.63 per cent, and n